1. Home
  2. TNYA vs DERM Comparison

TNYA vs DERM Comparison

Compare TNYA & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.69

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.45

Market Cap

190.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNYA
DERM
Founded
2016
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
168.2M
190.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
TNYA
DERM
Price
$0.69
$7.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.33
$12.67
AVG Volume (30 Days)
2.0M
209.9K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
54.96
34.72
EPS
N/A
N/A
Revenue
N/A
$61,858,000.00
Revenue This Year
N/A
$39.72
Revenue Next Year
N/A
$63.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
10.20
52 Week Low
$0.53
$4.31
52 Week High
$2.35
$9.56

Technical Indicators

Market Signals
Indicator
TNYA
DERM
Relative Strength Index (RSI) 41.07 61.47
Support Level $0.65 $7.39
Resistance Level $0.81 $8.29
Average True Range (ATR) 0.03 0.44
MACD -0.00 0.09
Stochastic Oscillator 26.13 68.27

Price Performance

Historical Comparison
TNYA
DERM

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Share on Social Networks: